FRI-183-A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results
作者
Pietro Lampertico,Marı́a Buti,Scott Fung,Sang Hoon Ahn,Wan‐Long Chuang,Alnoor Ramji,Won Young Tak,Chi-Yi Chen,Edward Tam,Ho Bae,Xiaoli Ma,John F. Flaherty,Anuj Gaggar,Audrey Lau,Becket Feierbach,George Y. Wu,Vithika Suri,Mani Subramanian,Huy N. Trinh,Seung Kew Yoon